• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXSL1700067 人源抗CD38单克隆抗体(Daratumumab)皮下注射液 daratumumab Injection Biological Products Import Drug Application 2017-10-23 Janssen Research & Development, LLC Janssen Research & Development LLC Certificate Issued 2018-08-09 view
JXSL1700081 人源抗CD38单克隆抗体(Daratumumab)皮下注射液 daratumumab Injection Biological Products Import Drug Application 2017-11-29 Janssen Research & Development, LLC Janssen Research & Development LLC Certificate Issued 2018-09-04 view
JXSL1700082 人源抗CD38单克隆抗体(Daratumumab)皮下注射液 daratumumab Injection Biological Products Import Drug Application 2017-11-29 Janssen Research & Development, LLC Janssen Research & Development LLC Certificate Issued 2018-08-27 view
JYSB1800241 人源抗CD38单克隆抗体(Daratumumab)皮下注射液 daratumumab Injection Biological Products Supplementary Application 2018-11-12 Janssen Research & Development, LLC Janssen Research & Development LLC;Cilag AG In Review 2018-11-10 view
JYSB1800240 人源抗CD38单克隆抗体(Daratumumab)皮下注射液 daratumumab Injection Biological Products Supplementary Application 2018-11-12 Janssen Research & Development, LLC Janssen Research & Development LLC;Cilag AG In Review 2018-11-10 view
JXSL1900053 人源抗CD38单克隆抗体(Daratumumab)皮下注射液 daratumumab Injection Biological Products Import Drug Application 2019-06-06 西安杨森制药有限公司 Xian Janssen Pharmaceutical Ltd;Janssen Research & Development LLC In Review 2019-06-05 view
JYSB1900146 人源抗CD38单克隆抗体(Daratumumab)皮下注射液 daratumumab Injection Biological Products Supplementary Application 2019-07-17 Janssen Research & Development, LLC Janssen Research & Development LLC;Cilag AG Certificate Issued 2019-08-05 view